Bayer

Member of UN Global Compact

Headquarters in Germany

Bayer website

🔎 Run a search for “Bayer”

Get RSS feed of these results

All stories

Article
11 May 2015
+ Español - Hide

“Vía Campesina entrega estudios sobre transgénicos en la Embajada de Ecuador en Brasilia”...

Read more

Article
6 March 2015
+ Français - Hide

Author: Claire Stam, Novethic (France) (copyright: www.novethic.fr)

« Pesticides : La stratégie "deux poids, deux mesures" du groupe Bayer », 3 mars 2015...

Read more

  • Related companies: Bayer
Company response
4 February 2015
+ Deutsch - Hide

Author: Bayer

...Bayer verwehrt sich gegen diese Unterstellung.Bayer ist ein global operierendes Unternehmen, das sich mit seinem Stammsitz in Leverkusen und seinen Aktivitäten dem Standort Deutschland verpflichtet fühlt...Die besondere Bedeutung des Standorts...

Read full response

Company response
4 February 2015

Bayer's response

Author: Bayer

Bayer is defending itself against this accusation. Bayer is a global company that is strongly committed to Germany due to its operations and the location of the headquarters in Leverkusen. We pay tax in all relevant countries on the basis of the added...

Read full response

Story
4 February 2015

NGO says Bayer's tax practices harm taxpayers & municipalities in Germany

See full story

Story
4 February 2015
+ Deutsch - Hide
Article
21 January 2015
+ Español - Hide

Author: Elva Mendoza, Contralínea (México)

“Transnacionales liberan, por "accidente", 800 toneladas de transgénicos", 18 de enero de 2015...

Read more

Article
13 January 2015

India spurns Gilead over hepatitis C patent

Author: AMy Kazmin & Andrew Ward, Financial Times

India’s patent controller has rejected a patent application from Gilead Sciences for a key compound for its blockbuster hepatitis C drug Sovaldi, a refusal that activists said would allow Indian companies immediately to start producing cheap generic...

Read more

Article
17 December 2014

Bayer loses bid to overturn India's first compulsory licence

Author: Lynne Taylor, Pharmatimes

German drug major Bayer has lost its long-running battle to get India’s first-ever compulsory licence – for its liver and kidney cancer drug Nexavar (sorafenib tosylate) – overturned...The multinational has been seeking to get the compulsory license...

Read more

Article
18 November 2014

Media Kit 2014 Index

Author: Access to Medicines Index

Includes:...

Read more